There’s a third choice, which is not getting the vaccine because you already have natural resistance to COVID, such as through a previous infection with COVID. In this case, a vaccine could introduce unnecessary risk.
What I'm still curious about is re: the risks of the naturally immune taking the vaccine. If they're immune, wouldn't they have fast deployment of antibodies to the vaccine-induced creation of the s-protein? Then surely it wouldn't be any greater risk than catching covid again, right? Meaning both situations (getting vaxx or getting covid again) would likely result in mild or no reaction (presuming an otherwise healthy risk profile). What am I missing?
One very small (but real) risk of the RNA vaccines is that it is quite difficult to dose the s-protein production. The amount of cellular uptake of the lipids envelopes, efficiency of ribosomes and many other factors play a role. The vaccine RNA is optimized to promote transcription. Someone who's cells are naturally happen to be great at transcription may create a lot more s-protein than someone else.
Too much s-protein can provoke a higher than optimal immune response which can also be dangerous.
Ok. I guess my question was: would it be safer for an otherwise healthy person that had covid and recovered to face covid again or to get the vaccine? And I guess the answer is: "it depends" - chiefly on which produces a larger viral load. And that might depend on how much virus you get sneezed into the open wound you're getting stitched up by the roadside Guatemalan doctor skimping on mask costs whose been feeling a wee bit snotty that afternoon. Or whether your cells produce more than is necessary and you have a bad immune response.
AIRx Health | Software Engineer | SF Bay Area | Full-time | Remote
AIRx Health is building the next-generation digital healthcare company for chronic conditions and for COVID-19. If you're interested in saving lives with every push of code, apply now to join our growing team. We're already making a big impact in helping people with COVID-19 and chronic conditions, including lung disease and hypertension, and are backed by notable investors, such as Village Global, ACME Capital, and Y Combinator. Ideal candidates will have 3+ years experience and enjoy regularly shipping code. We cover all healthcare for employees and dependents, provide a matching 401(k), and contribute to employees' student loan payments.
Our tech stack includes Python, Django, PostgreSQL, AWS, and JavaScript.
DoseDr | Full-Stack Engineer | San Francisco | Full-Time, Onsite
DoseDr is hiring a Full-Stack Engineer with over 3 years of professional experience to help us transform chronic illness care.
DoseDr’s telemedicine platform allows doctors to remotely treat chronic illness patients, such as diabetics. Doctors use our web portal to provide treatment to patients through our mobile app. Our users experience fewer medical complications from chronic illness, resulting in healthier and longer lives, while reducing costs for insurers and healthcare systems.
We develop technology that prevents medical complications from diabetes and other chronic illnesses, saving the lives of our patients and improving the quality of life for them and their families. We are a team of coders, data scientists, medical doctors, and business professionals from Yale, Stanford, and Harvard.
DoseDr recently raised a strong seed round and is backed by the world's top startup accelerator, Y Combinator.
